Alzheimer’s disease is one of the most challenging brain conditions in the world today. It mainly affects older adults and slowly damages memory, thinking ability, and daily functioning.
As the disease progresses, people may forget familiar faces, lose track of time, and struggle with simple everyday tasks. For families, it can be heartbreaking to watch their loved ones change over time.
The main cause of Alzheimer’s disease is believed to be the buildup of harmful proteins in the brain, often called plaques. These plaques interfere with how brain cells communicate with each other.
For many years, scientists have focused on removing these plaques as a way to treat the disease. Some newer drugs, such as lecanemab and aducanumab, can help reduce plaque levels and slow down memory decline. However, these treatments cannot bring back memories that have already been lost.
Now, researchers at UCLA Health have taken a different approach. Instead of targeting the plaques directly, they focused on how the brain processes memory. Their study, which explores a new compound called DDL-920, suggests that it may be possible to restore memory by improving how brain cells work together.
The brain does not work randomly. It uses patterns of electrical activity, often described as rhythms or waves, to process information. One of the most important types of brain waves for memory is called gamma oscillation.
These waves help different parts of the brain communicate quickly and efficiently. In healthy brains, gamma waves are strong and well-organized. But in people with Alzheimer’s disease, these waves become weaker and less coordinated.
Scientists believe that this loss of rhythm may play a key role in memory problems. In the past, researchers have tried to improve gamma waves using external methods, such as flashing lights, sound stimulation, or magnetic devices. While some of these methods helped reduce plaque in the brain, they did not significantly improve memory or thinking.
The UCLA team decided to take a new path. Instead of using external tools, they aimed to restore the brain’s rhythm from within. They focused on a special group of brain cells called parvalbumin interneurons. These cells are very important because they help generate and maintain gamma oscillations.
However, these cells also have built-in “brakes” that can slow them down. These brakes are special receptors that reduce the activity of the cells. In Alzheimer’s disease, these brakes may become too strong, weakening the brain’s natural rhythms.
The researchers discovered that the compound DDL-920 can block these brakes. By doing this, it allows the brain cells to stay active and maintain strong gamma waves. This helps restore the communication between brain regions that is needed for memory.
To test their idea, the scientists used mice that showed symptoms similar to Alzheimer’s disease. These mice were tested using a tool called the Barnes maze, which is designed to measure memory and learning. In this test, mice must remember the location of an escape hole on a platform.
Before treatment, the Alzheimer’s-like mice had difficulty finding the correct location. Their performance showed clear memory problems. However, after receiving DDL-920 for two weeks, the results changed dramatically. The treated mice performed just as well as healthy mice. They were able to remember the correct location and complete the task successfully.
Another important finding was that the mice did not show any unusual behavior or side effects during the treatment. This suggests that the compound may be safe, although much more research is needed before it can be tested in humans.
Dr. Istvan Mody, who led the study, explained that this approach is very different from current treatments. Instead of simply slowing down the disease, it may actually help restore lost brain function. However, he also emphasized that more studies are needed to confirm these results and ensure safety in people.
This discovery could have a wider impact beyond Alzheimer’s disease. Weak gamma brain waves have also been observed in other conditions, including depression, schizophrenia, and autism. If DDL-920 proves effective, it could potentially help in treating these disorders as well.
Although the research is still in its early stages, it offers real hope. For many years, treatments for Alzheimer’s have focused on slowing decline. This new approach suggests that it might one day be possible to recover some lost memory.
For patients and families affected by Alzheimer’s disease, even small improvements can make a meaningful difference. This study reminds us that science is still moving forward, and new ideas can lead to breakthroughs that once seemed impossible.
If you care about brain health, please read studies about vitamin D deficiency linked to Alzheimer’s and vascular dementia, and higher magnesium intake could help benefit brain health.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and coconut oil could help improve cognitive function in Alzheimer’s.
Copyright © 2026 Knowridge Science Report. All rights reserved.
